New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2013
09:21 EDTGSKMaryland files suit against GlaxoSmithKline over marketing of drugs
Attorney General Douglas Gansler announced yesterday that Maryland has filed suit against GlaxoSmithKline over that company's alleged misleading marketing of the prescription drugs Avandia, Avandamet and Avandaryl, used to treat diabetes. The lawsuit alleges that GlaxoSmithKline touted the drugs as superior to other diabetes medications even though they were not, in fact, better at treating the disease. The lawsuit also alleges that the company withheld data showing that these drugs dramatically increase a patient's chances of suffering a heart attack or other serious adverse events. Despite its knowledge of these risks, GlaxoSmithKline promoted the drug as safe for use, the AG said.
News For GSK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 18, 2014
09:21 EDTGSKOn The Fly: Pre-market Movers
Subscribe for More Information
07:15 EDTGSKAgenus reports GSK ZOE-50 Phase 3 study met primary endpoint
Subscribe for More Information
December 9, 2014
10:23 EDTGSKOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:10 EDTGSKARIAD takeover rumors rekindled, Independent says
Subscribe for More Information
07:44 EDTGSKAmerican Association for Cancer Research to hold a symposium
Subscribe for More Information
05:37 EDTGSKGlaxoSmithKline downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill downgraded GlaxoSmithKline to Underperform citing a lack of pipeline catalysts and its belief the European pharma sector is close to fair value.
December 8, 2014
13:32 EDTGSKEpizyme announces results for PRMT5 inhibitor
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use